Alejandro Olaviaga , Leandro Nicolás Grendas , Luciana Carla Chiapella , Romina Isabel Álvarez Casiani , Ángeles Romina Arena , Vera Tifner , Cintia Romina Prokopez , Eugenio Antonio Carrera Silva , Andrea Emilse Errasti , Federico Manuel Daray
{"title":"sTREM2在威胁生命事件和抑郁之间的中介作用","authors":"Alejandro Olaviaga , Leandro Nicolás Grendas , Luciana Carla Chiapella , Romina Isabel Álvarez Casiani , Ángeles Romina Arena , Vera Tifner , Cintia Romina Prokopez , Eugenio Antonio Carrera Silva , Andrea Emilse Errasti , Federico Manuel Daray","doi":"10.1016/j.jneuroim.2025.578719","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Depression is a highly prevalent and disabling condition, affecting approximately 280 million people globally. Emerging evidence points to a significant role of neuroinflammation in the pathophysiology of depression. The soluble triggering receptor expressed on myeloid cells-2 (sTREM2) has been identified as a potential marker of neuroinflammation.</div></div><div><h3>Objective</h3><div>This study aims to investigate the potential mediating role of sTREM2 in the relationship between perceived stress, measured by the List of Threatening Events, and current depressive symptoms in patients with major depressive episodes (MDE).</div></div><div><h3>Methods</h3><div>This secondary analysis was conducted on data from a multicenter, case-control study of participants with current MDE (<em>n</em> = 39) and healthy controls (HC, <em>n</em> = 42). Plasma sTREM2 levels were measured using bead-based multiplex assays. Depression was assessed using the Hamilton Depression Rating Scale (HDRS-17) and Life-Threatening Events (LTE) were quantified with the Stressful Life Events Scale. A mediation analysis was conducted to explore the role of sTREM2 in the relationship between depression and LTE.</div></div><div><h3>Results</h3><div>Patients with current MDE exhibited higher plasma sTREM2 levels compared to HC (<em>p</em> = 0.006). Recent stress was positively associated with sTREM2 (<em>p</em> = 0.032), and both LTE scores and sTREM2 levels were significant predictors of current MDE (<em>p</em> = 0.009, <em>p</em> = 0.035). Mediation analysis showed that sTREM2 accounted for 17 % of the relationship between recent stress and depression (<em>p</em> = 0.028).</div></div><div><h3>Conclusion</h3><div>Our findings suggest that sTREM2 may play a mediating role in the link between stress and depression, highlighting neuroinflammation as a potential pathway in the development of depression.</div></div>","PeriodicalId":16671,"journal":{"name":"Journal of neuroimmunology","volume":"407 ","pages":"Article 578719"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"sTREM2 as a mediator in the association between life-threatening events and depression\",\"authors\":\"Alejandro Olaviaga , Leandro Nicolás Grendas , Luciana Carla Chiapella , Romina Isabel Álvarez Casiani , Ángeles Romina Arena , Vera Tifner , Cintia Romina Prokopez , Eugenio Antonio Carrera Silva , Andrea Emilse Errasti , Federico Manuel Daray\",\"doi\":\"10.1016/j.jneuroim.2025.578719\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Depression is a highly prevalent and disabling condition, affecting approximately 280 million people globally. Emerging evidence points to a significant role of neuroinflammation in the pathophysiology of depression. The soluble triggering receptor expressed on myeloid cells-2 (sTREM2) has been identified as a potential marker of neuroinflammation.</div></div><div><h3>Objective</h3><div>This study aims to investigate the potential mediating role of sTREM2 in the relationship between perceived stress, measured by the List of Threatening Events, and current depressive symptoms in patients with major depressive episodes (MDE).</div></div><div><h3>Methods</h3><div>This secondary analysis was conducted on data from a multicenter, case-control study of participants with current MDE (<em>n</em> = 39) and healthy controls (HC, <em>n</em> = 42). Plasma sTREM2 levels were measured using bead-based multiplex assays. Depression was assessed using the Hamilton Depression Rating Scale (HDRS-17) and Life-Threatening Events (LTE) were quantified with the Stressful Life Events Scale. A mediation analysis was conducted to explore the role of sTREM2 in the relationship between depression and LTE.</div></div><div><h3>Results</h3><div>Patients with current MDE exhibited higher plasma sTREM2 levels compared to HC (<em>p</em> = 0.006). Recent stress was positively associated with sTREM2 (<em>p</em> = 0.032), and both LTE scores and sTREM2 levels were significant predictors of current MDE (<em>p</em> = 0.009, <em>p</em> = 0.035). Mediation analysis showed that sTREM2 accounted for 17 % of the relationship between recent stress and depression (<em>p</em> = 0.028).</div></div><div><h3>Conclusion</h3><div>Our findings suggest that sTREM2 may play a mediating role in the link between stress and depression, highlighting neuroinflammation as a potential pathway in the development of depression.</div></div>\",\"PeriodicalId\":16671,\"journal\":{\"name\":\"Journal of neuroimmunology\",\"volume\":\"407 \",\"pages\":\"Article 578719\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-08-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of neuroimmunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165572825002000\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroimmunology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165572825002000","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
sTREM2 as a mediator in the association between life-threatening events and depression
Background
Depression is a highly prevalent and disabling condition, affecting approximately 280 million people globally. Emerging evidence points to a significant role of neuroinflammation in the pathophysiology of depression. The soluble triggering receptor expressed on myeloid cells-2 (sTREM2) has been identified as a potential marker of neuroinflammation.
Objective
This study aims to investigate the potential mediating role of sTREM2 in the relationship between perceived stress, measured by the List of Threatening Events, and current depressive symptoms in patients with major depressive episodes (MDE).
Methods
This secondary analysis was conducted on data from a multicenter, case-control study of participants with current MDE (n = 39) and healthy controls (HC, n = 42). Plasma sTREM2 levels were measured using bead-based multiplex assays. Depression was assessed using the Hamilton Depression Rating Scale (HDRS-17) and Life-Threatening Events (LTE) were quantified with the Stressful Life Events Scale. A mediation analysis was conducted to explore the role of sTREM2 in the relationship between depression and LTE.
Results
Patients with current MDE exhibited higher plasma sTREM2 levels compared to HC (p = 0.006). Recent stress was positively associated with sTREM2 (p = 0.032), and both LTE scores and sTREM2 levels were significant predictors of current MDE (p = 0.009, p = 0.035). Mediation analysis showed that sTREM2 accounted for 17 % of the relationship between recent stress and depression (p = 0.028).
Conclusion
Our findings suggest that sTREM2 may play a mediating role in the link between stress and depression, highlighting neuroinflammation as a potential pathway in the development of depression.
期刊介绍:
The Journal of Neuroimmunology affords a forum for the publication of works applying immunologic methodology to the furtherance of the neurological sciences. Studies on all branches of the neurosciences, particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays), are considered for publication.